Compare VERA & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | CNK |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | 18300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.3B |
| IPO Year | 2021 | 2007 |
| Metric | VERA | CNK |
|---|---|---|
| Price | $40.00 | $27.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $81.30 | $32.90 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $3,115,000,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $445.28 | $3.68 |
| P/E Ratio | ★ N/A | $27.07 |
| Revenue Growth | N/A | ★ 2.15 |
| 52 Week Low | $18.53 | $21.60 |
| 52 Week High | $56.05 | $34.01 |
| Indicator | VERA | CNK |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 57.56 |
| Support Level | $37.20 | $27.27 |
| Resistance Level | $43.21 | $29.17 |
| Average True Range (ATR) | 2.51 | 0.89 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 45.09 | 75.81 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.